Federal Trade Commission

Feds expand probe into new layer of drug middlemen

BY: - June 21, 2023

The Federal Trade Commission this month announced that it was expanding its probe into drug middlemen — companies accused of increasing the cost of prescription drugs through secretive, one-sided arrangements with drugmakers and pharmacies. Specifically, it added a third company created by one of the biggest middlemen to its investigation. The commission, which polices anti-competitive […]